Diagnosis of non-osseous spinal metastatic disease: the role of PET/CT and PET/MRI

被引:0
|
作者
Ali Batouli
John Braun
Kamal Singh
Ali Gholamrezanezhad
Bethany U. Casagranda
Abass Alavi
机构
[1] Allegheny Health Network,Department of Radiology
[2] Case Western Reserve University,Department of Radiology, University Hospitals of Cleveland
[3] Hospital of the University of Pennsylvania,Department of Radiology
来源
Journal of Neuro-Oncology | 2018年 / 138卷
关键词
PET/CT; PET/MRI; Positron emissions tomography; Spinal tumor; Spinal metastatic disease; Spinal cord;
D O I
暂无
中图分类号
学科分类号
摘要
The spine is the third most common site for distant metastasis in cancer patients with approximately 70% of patients with metastatic cancer having spinal involvement. Positron emission tomography (PET), combined with computed tomography (CT) or magnetic resonance imaging (MRI), has been deeply integrated in modern clinical oncology as a pivotal component of the diagnostic work-up of patients with cancer. PET is able to diagnose several neoplastic processes before any detectable morphological changes can be identified by anatomic imaging modalities alone. In this review, we discuss the role of PET/CT and PET/MRI in the diagnostic management of non-osseous metastatic disease of the spinal canal. While sometimes subtle, recognizing such disease on FDG PET/CT and PET/MRI imaging done routinely in cancer patients can guide treatment strategies to potentially prevent irreversible neurological damage.
引用
收藏
页码:221 / 230
页数:9
相关论文
共 50 条
  • [1] Diagnosis of non-osseous spinal metastatic disease: the role of PET/CT and PET/MRI
    Batouli, Ali
    Braun, John
    Singh, Kamal
    Gholamrezanezhad, Ali
    Casagranda, Bethany U.
    Alavi, Abass
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2018, 138 (02) : 221 - 230
  • [2] Non-osseous imaging manifestations of plasma cell dyscrasias on PET/CT
    Johnson, Geoffrey
    Peller, Patrick
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [3] FDG-PET/CT for the evaluation of non-osseous sites of Langerhans cell histiocytosis
    Dahmoush, Hisham
    Goodkind, Alison
    Grant, Frederick
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [4] FDG-PET for imaging of non-osseous infection and inflammation
    Vos, F. J.
    Bleeker-Rovers, C. P.
    Corstens, F. H. M.
    Kullberg, B. J.
    Oyen, W. J. G.
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 50 (02): : 121 - 130
  • [5] Non-osseous Tubercular Lesions of Spinal and Paraspinal Region-Evaluation by MRI
    Sivalingam, Jaiganesh
    Kumar, Anil
    Rajasekhar, Konduru Varadarajulu
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (02)
  • [6] SODIUM FLUORIDE PET/CT: A SUPERIOR IMAGING MODALITY IN EVALUATION OF OSSEOUS METASTATIC DISEASE
    Harrold, Emily
    Murphy, Jennifer
    O'Reilly, Seamus
    O'Reagan, Kevin
    [J]. BREAST, 2015, 24 : S63 - S64
  • [7] Sodium fluoride PET/CT - a superior imaging modality in confirmation of osseous metastatic disease?
    Harrold, E.
    O'Leary, C.
    Collins, D.
    O'Reilly, S.
    Murphy, J.
    O'Reagan, K.
    [J]. BREAST, 2015, 24 : S86 - S86
  • [8] PET/CT and MRI of intra-osseous haemangioma of the tibia
    Cha, J. G.
    Yoo, J. H.
    Kim, H. K.
    Park, J. M.
    Paik, S. H.
    Park, S. J.
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2012, 85 (1012): : E94 - E98
  • [9] The role of hypofractionated radiation in the management of non-osseous metastatic or uncontrolled local cancer
    Johnstone, Candice
    Lutz, Stephen T.
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2014, 3 (04) : 291 - 303
  • [10] An update on the role of PET/CT and PET/MRI in ovarian cancer
    Khiewvan, Benjapa
    Torigian, Drew A.
    Emamzadehfard, Sahra
    Paydary, Koosha
    Salavati, Ali
    Houshmand, Sina
    Werner, Thomas J.
    Alavi, Abass
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (06) : 1079 - 1091